This evaluation should include assessment of thyroid function optimization, screening for contraindications, review of potential drug interactions, and establishment of a monitoring plan
By combining these analyses, we provide scientifically defensible proof of sameness
Hernandez AF, Green JB, Janmohamed S, DAgostino RB Sr, Granger CB, Jones NP, Leiter LA, Rosenberg AE, Sigmon KN, Somerville MC, Thorpe KM, McMurray JJV, Del Prato S, Harmony Outcomes committees and investigators
The magnitude of decrease in K-18 observed with retatrutide 8 mg and 12 mg has been associated with greater odds of histological improvement in previous studies of patients with MASH 33